Nicotine is usually discussed as an addictive drug. But in 1959, researchers noticed something unexpected: people who smoked appeared less likely to develop Parkinson’s disease. That observation survived decades of scrutiny and eventually led to animal experiments, memory studies, nicotine patches, and major clinical trials. This investigation follows that evidence from the original anomaly to the latest human research to determine what nicotine actually does to the brain—and whether its neuroprotective reputation has been earned.

Time Stamps

0:00 – Intro
1:44 – Reverse causation theory
2:32 – The Swedish snus study
4:00 – Animal trials: mice vs. monkeys
5:16 – Nicotine's effect on the brain
7:35 – The NIC-PD trial
9:04 – The MIND trial
11:31 – The 2009 paper that predicted the failure
12:55 – What the evidence actually shows

Microplastics have been detected in human brain tissue, and in 2025 one study produced a number that spread around the world: roughly a spoonful of plastic in the brain. But the closer you look at how that number was produced, the stranger the story becomes. This investigation follows the evidence to find out what is actually accumulating in our brains, how much is there, and whether it is doing harm.

Time Stamps

0:00 – The spoonful of plastic claim
1:00 – What the first brain study found
3:35 – An experiment inside living brain vessels
5:29 – The dementia finding
6:54 – A second human brain study
8:49 – How scientists measure plastic in tissue
10:15 – Another way plastic could affect the brain
12:02 – Where things stand now

BPC-157 is now used as a recovery peptide for tendon injuries, muscle strains, and stubborn joint problems. Some people report remarkable results, while others feel nothing. But its story did not begin in sports medicine. It traces back through human stomach fluid, an old Yugoslav research program, pharmaceutical development, and decades of experiments that still leave major parts of the peptide’s history unresolved. This investigation follows that evidence from the beginning to find out what BPC-157 actually is, what it may be doing, and how it became the healing peptide.

Time stamps:

0:00 – What BPC-157 really is
2:02 – How it got its name
4:50 – What the animal studies show
8:33 – The science that still doesn't add up
10:28 – A stability problem nobody talks about
12:17 – The human trial history
13:43 – A missing piece in the story
15:17 – What the evidence still doesn't prove
16:29 – Where things stand now